Prostate Cancer - Results from #28400

CURy 2011 - Prostate biopsy: Update 2011 - Slide Presentation March 23, 2011

CURy 2011 - Interest of multi-parametric MRI in early prostate cancer - Slide Presentation March 23, 2011

CURy 2011 - Pathological basis for focal therapy - Slide Presentation March 23, 2011

Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling - Abstract March 22, 2011

The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy - Abstract March 22, 2011

Moderate dose escalation with single-fraction high-dose rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-Year outcome of the first 100 consecutively treated patients - Abstract March 22, 2011

Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer - Abstract March 22, 2011

The example of CaPSURE: Lessons learned from a national disease registry - Abstract March 22, 2011

Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology - Abstract March 22, 2011

Transrectal ultrasound approach for identification and radioguided biopsy of sentinel node in lymph node staging of localized prostate cancer - Abstract March 21, 2011

Diagnosis of high-grade prostatic intraepithelial neoplasia: The impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy - Abstract March 21, 2011

Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptoms - Abstract March 21, 2011

Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer - Abstract March 21, 2011

Functional and oncological outcomes of men under 60 years of age having endoscopic surgery for prostate cancer are optimal following intrafascial endoscopic extraperitoneal radical prostatectomy - Abstract March 21, 2011

Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature - Abstract March 21, 2011

Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence - Abstract March 21, 2011

Neoadjuvant hormonal therapy preceding radical prostatectomy for clinically localized prostate cancer: Early postoperative complications and biochemical recurrence - Abstract March 21, 2011

Management of rising prostate-specific antigen after a negative biopsy - Abstract March 21, 2011

Biopsy of the anterior prostate gland: Technique with end-fire transrectal ultrasound - Abstract March 21, 2011

High-intensity focused ultrasound (HIFU) in prostate cancer: A single centre experience in patients with low, intermediate or high-risk of progression - Abstract March 21, 2011

Page 1421 of 1436